It has been demonstrated that abnormal expression of KIF20A is observed in various solid tumors, including glioma, hepatocarcinoma, breast cancer, nasopharyngeal cancer, gastric cancer, and lung cancer30. Here, KIF20A is linked to nasopharyngeal carcinoma.